Current issues in the pharmacologic management of obsessive compulsive disorder

S A Rasmussen; J L Eisen; M T Pato

Current issues in the pharmacologic management of obsessive compulsive disorder

J Clin Psychiatry. 1993 Jun:54 Suppl:4-9.

Authors

S A Rasmussen¹, J L Eisen, M T Pato

Affiliation

¹ Department of Psychiatry and Human Behavior, Brown University, Providence, R.I. 02906.

PMID: 8101187

Abstract

In spite of significant advances in the development of behavioral and pharmacologic strategies for the treatment of obsessive compulsive disorder, little is known about the comparative efficacy and safety of those treatments. In addition, questions about the dose and duration in maintenance treatment remain unknown. This article reviews current issues in the pharmacologic management of patients with obsessive compulsive disorder.

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Anti-Anxiety Agents / therapeutic use
Antipsychotic Agents / therapeutic use
Behavior Therapy
Clinical Trials as Topic
Combined Modality Therapy
Dose-Response Relationship, Drug
Drug Administration Schedule
Humans
Monoamine Oxidase Inhibitors / therapeutic use
Multicenter Studies as Topic
Obsessive-Compulsive Disorder / drug therapy*
Obsessive-Compulsive Disorder / prevention & control
Obsessive-Compulsive Disorder / psychology
Selective Serotonin Reuptake Inhibitors / therapeutic use

Substances

Anti-Anxiety Agents
Antipsychotic Agents
Monoamine Oxidase Inhibitors
Serotonin Uptake Inhibitors